123I-MIBG SPECT may help ID risk of ventricular tachyarrhythmias

10/17/2011 | CardiovascularBusiness.com

German researchers who performed 123I-MIBG SPECT on 42 patients with definite arrhythmogenic right ventricular cardiomyopathy found that those with abnormal results experienced life-threatening ventricular tachyarrhythmias more often. The patients were monitored for 11.9 years. The "observed predisposition to future ventricular tachyarrhythmias in patients with a reduced 123I-MIBG uptake could eventually lead to the recognition of 123I-MIBG SPECT as an indicator of an increased individual risk of future arrhythmic events," according to the study published in the Journal of Nuclear Medicine.

View Full Article in:

CardiovascularBusiness.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC